Over the 90-day window ending January 10, 2026, Aclaris Therapeutics's three dominant insider ownership positions are held by TenPercentOwner Braden Michael Leonard (14.25Mn shares), TenPercentOwner Capital Management Iii, Llc Foresite (3.40Mn shares), Ceo Neal Walker (1.50Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Braden Michael Leonard | 14,250,000 | 05 Aug, 2024 | |
| Capital Management Iii, Llc Foresite | 3,399,034 | 03 Nov, 2021 | |
| Neal Walker | Ceo | 1,499,022 | 05 Jan, 2026 |
| Anand Mehra | 714,823 | 09 Jun, 2025 | |
| Andrew N Schiff | 448,415 | 09 Jun, 2025 | |
| Joseph Monahan | Chief Scientific Officer | 265,662 | 04 Mar, 2025 |
| Frank Ruffo | Chief Financial Officer | 201,883 | 14 Mar, 2022 |
| Kevin Balthaser | Chief Financial Officer | 160,413 | 05 Jan, 2026 |
| Kamil Ali-Jackson | Chief Legal Officer | 160,214 | 05 Jan, 2022 |
| James Loerop | Chief Business Officer | 155,041 | 05 Jan, 2026 |
| David N. Gordon | Chief Medical Officer | 147,447 | 14 Jul, 2021 |
| Christopher P. Molineaux | 57,956 | 09 Jun, 2025 | |
| Douglas J. Manion | Pres And Ceo | 41,813 | 03 Jan, 2024 |
| William D. Humphries | 33,525 | 09 Jun, 2025 | |
| Andrew Kenneth William Powell | 33,523 | 04 Jun, 2024 | |
| Bryan M. Reasons | 28,732 | 04 Jun, 2024 | |
| Hugh M. Davis | President And Coo | 26,750 | 04 Dec, 2025 |
| Maxine Gowen | 21,754 | 09 Jun, 2025 | |
| Vincent Milano | 17,316 | 09 Jun, 2025 | |
| Gail Cawkwell | Chief Medical Officer | 9,593 | 05 Jul, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Jan, 2026 | Neal Walker | Common Stock | D | 9,952 | $2.88 | 1,499,022 | D | F |
| 02 Jan, 2026 | Neal Walker | Common Stock | A | 29,150 | - | 1,508,974 | D | M |
| 02 Jan, 2026 | James Loerop | Common Stock | D | 6,171 | $2.88 | 155,041 | D | F |
| 02 Jan, 2026 | James Loerop | - | - | 155,041 | D | |||
| 02 Jan, 2026 | James Loerop | Common Stock | A | 18,150 | - | 161,212 | D | M |
| 02 Jan, 2026 | James Loerop | - | - | 161,212 | D | |||
| 02 Jan, 2026 | Kevin Balthaser | - | - | 160,413 | D | |||
| 02 Jan, 2026 | Kevin Balthaser | Common Stock | A | 13,200 | - | 164,874 | D | M |
| 02 Jan, 2026 | Kevin Balthaser | - | - | 164,874 | D | |||
| 02 Jan, 2026 | Kevin Balthaser | Common Stock | D | 4,461 | $2.88 | 160,413 | D | F |
| 01 Jan, 2026 | Kevin Balthaser | - | - | 153,924 | D | |||
| 01 Jan, 2026 | Kevin Balthaser | Common Stock | A | 7,500 | - | 153,924 | D | M |
| 01 Jan, 2026 | Kevin Balthaser | Common Stock | D | 2,250 | $3.01 | 151,674 | D | F |
| 01 Jan, 2026 | Kevin Balthaser | - | - | 151,674 | D | |||
| 31 Dec, 2025 | James Loerop | Common Stock | A | 73,750 | - | 177,056 | D | M |
| 31 Dec, 2025 | James Loerop | - | - | 177,056 | D | |||
| 31 Dec, 2025 | James Loerop | - | - | 143,062 | D | |||
| 31 Dec, 2025 | James Loerop | Common Stock | D | 33,994 | $3.01 | 143,062 | D | F |
| 31 Dec, 2025 | Kevin Balthaser | Common Stock | A | 73,750 | - | 166,358 | D | M |
| 31 Dec, 2025 | Kevin Balthaser | Common Stock | D | 19,934 | $3.01 | 146,424 | D | F |